Crossmark

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan

Crossref DOI link: https://doi.org/10.1186/s13063-024-08036-6

Published Online: 2024-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mackenzie, Grant A. http://orcid.org/0000-0002-4994-2627
Osei, Isaac

Salaudeen, Rasheed

Licciardi, Paul V.

Greenwood, Brian

Mulholland, Kim

Nguyen, Cattram
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation (INV006724)

Medical Research Council (MR-V011626-1)

UK Research and Innovation
License Information

Text and Data Mining valid from 2024-03-26

Version of Record valid from 2024-03-26
More Information

Article History

Received: 4 September 2023

Accepted: 4 March 2024

First Online: 26 March 2024

Declarations

:

: The trial was approved by the GG/MRCG Joint Ethics Committee (ethics reference 17683) and the LSHTM EC (ethics reference 17683). Written, informed consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below